Barbara Schmalfeldt

Barbara Schmalfeldt

UNVERIFIED PROFILE

Are you Barbara Schmalfeldt?   Register this Author

Register author
Barbara Schmalfeldt

Barbara Schmalfeldt

Publications by authors named "Barbara Schmalfeldt"

Are you Barbara Schmalfeldt?   Register this Author

84Publications

2544Reads

13Profile Views

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.

Br J Cancer 2019 Nov 29;121(11):944-953. Epub 2019 Oct 29.

Department of Gynecology, University Medical Centre Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0607-2DOI Listing
November 2019

Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients.

Breast Cancer Res Treat 2019 Oct 23. Epub 2019 Oct 23.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05474-8DOI Listing
October 2019

Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis.

Int J Gynecol Cancer 2019 03 4;29(3):466-473. Epub 2019 Jan 4.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2018-000046DOI Listing
March 2019

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.

N Engl J Med 2019 02;380(9):822-832

From the Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen (P. Harter, A. du Bois), Department of Gynecology, Charité-Universitätsmedizin Berlin, Berlin (J.S.), the Coordinating Center for Clinical Trials, Philipps University Marburg (A.R., C.S.-B.), and the Department of Gynecology and Obstetrics, University Hospital Giessen and Marburg (U.W.), Marburg, the Department of Gynecology and Obstetrics, Kaiserswerther Diakonie (B.L.), and the Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf (W.M.), Düsseldorf, the Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald (A.M.), the Department of Gynecology, University Medical Center Hamburg-Eppendorf (S.M.), and the Department of Gynecology and Obstetrics, Albertinen Krankenhaus (I.L.), Hamburg, University Women's Hospital, Department of Gynecology and Reproductive Medicine and Center for Gynecologic Oncology, Jena University Hospital, Jena (I.B.R.), the Department of Obstetrics and Gynecology, University Munich rechts der Isar (B.S.), and the Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-Universität München (A. Burges), Munich, West German Cancer Center, Department of Gynecology and Obstetrics, University of Duisburg-Essen, Duisburg (R.K.), the Department of Gynecology and Obstetrics, University Hospital Kiel, Kiel (F.H.), University Medical Center Freiburg, Freiburg (A.H.), University Medical Center Mainz, Department of Gynecology and Obstetrics, Mainz (A.H.), and the Department of Gynecology and Obstetrics, Hannover Medical School, Hannover (P. Hillemanns) - all in Germany; the Gynecologic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (D.L., F.R.), and the Department of Gynecologic Oncology, European Institute of Oncology, University of Milan (G.A.), Milan, the Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome (G.S.), Gynecologic Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli, IRCCS Fondazione G. Pascale, Naples (S.G.), and the Cancer Reference Center, Centro di Riferimento Oncologico, Aviano (G.G.) - all in Italy; the Department of Gynecological Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium (I.V.); the Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria (C.M.); the Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea (J.-W.K.); and the Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic (D.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1808424DOI Listing
February 2019

A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.

Biomaterials 2019 01 16;190-191:63-75. Epub 2018 Oct 16.

Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia; Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD 4102, Australia; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 801 Ferst Drive, Atlanta, GA 30332-0405, USA; Institute for Advanced Study, Technical University Munich, Lichtenbergstr. 2a, 85748 Garching, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01429612183072
Publisher Site
http://dx.doi.org/10.1016/j.biomaterials.2018.10.014DOI Listing
January 2019

Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.

Glycobiology 2018 11;28(11):898-903

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/glycob/cwy065DOI Listing
November 2018

Clinical relevance of cytoskeleton associated proteins for ovarian cancer.

J Cancer Res Clin Oncol 2018 Nov 9;144(11):2195-2205. Epub 2018 Aug 9.

Department of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-018-2710-9
Publisher Site
http://dx.doi.org/10.1007/s00432-018-2710-9DOI Listing
November 2018

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.

Dis Markers 2018 28;2018:6714287. Epub 2018 Jun 28.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/6714287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046165PMC
October 2018

Participation of elderly gynecological cancer patients in clinical trials.

Arch Gynecol Obstet 2018 10 30;298(4):797-804. Epub 2018 Aug 30.

Department of Gynecology and Gynecologic Oncology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-018-4886-2DOI Listing
October 2018

Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer.

Int J Gynecol Cancer 2018 09;28(7):1403-1409

Departments of Gynecology and Gynecologic Oncology, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001298DOI Listing
September 2018

[Current Status of Targeted Treatment in Breast Cancer].

Dtsch Med Wochenschr 2017 Nov 27;142(22):1669-1675. Epub 2017 Oct 27.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-108468DOI Listing
November 2017

Loss of promotor hypermethylation in recurrent high-grade ovarian cancer.

Oncotarget 2017 Oct 15;8(47):83063-83074. Epub 2017 Sep 15.

Department of Gynecology and Gynecologic Oncology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669950PMC
October 2017

Oral Human Papillomavirus in Women With High-Grade Cervical Intraepithelial Neoplasia.

J Low Genit Tract Dis 2017 Jul;21(3):177-183

1Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Germany; 2Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Germany; 3Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 4Department of Otorhinolaryngology, Head and Neck Surgery and Oncology, University Medical Centre Hamburg-Eppendorf, Germany; 5Department of Otolaryngology, Head and Neck Surgery, Asklepios Klinik Hamburg Altona, Germany; 6HNO-in-Altona, Private Otorhinolaryngology Praxis, Hamburg, Germany; 7Tagesklinik Altonaer Strasse, Private Gynaecology Praxis, Hamburg, Germany; and 8Department of Gynaecology and Gynaecologic Oncology, Medical Center Asklepios Altona, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LGT.0000000000000313DOI Listing
July 2017

Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience.

Breast Cancer Res Treat 2017 Jun 21;163(3):517-526. Epub 2017 Mar 21.

Department of Gynecology, University Medical Center, Martinistraße 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4208-6DOI Listing
June 2017

Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.

Breast Cancer Res Treat 2017 04 6;162(3):427-438. Epub 2017 Feb 6.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4135-6DOI Listing
April 2017

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Authors:
Lara E Sucheston-Campbell Rikki Cannioto Alyssa I Clay John Lewis Etter Kevin H Eng Song Liu Sebastiano Battaglia Qiang Hu J Brian Szender Albina Minlikeeva Janine M Joseph Paul Mayor Scott I Abrams Brahm H Segal Paul K Wallace Kah Teong Soh Emese Zsiros Hoda Anton-Culver Elisa V Bandera Matthias W Beckmann Andrew Berchuck Line Bjorge Amanda Bruegl Ian G Campbell Shawn Patrice Campbell Georgia Chenevix-Trench Daniel W Cramer Agnieszka Dansonka-Mieszkowska Fanny Dao Brenda Diergaarde Thilo Doerk Jennifer A Doherty Andreas du Bois Diana Eccles Svend Aage Engelholm Peter A Fasching Simon A Gayther Aleksandra Gentry-Maharaj Rosalind M Glasspool Marc T Goodman Jacek Gronwald Philipp Harter Alexander Hein Florian Heitz Peter Hillemmanns Claus Høgdall Estrid V S Høgdall Tomasz Huzarski Allan Jensen Sharon E Johnatty Audrey Jung Beth Y Karlan Reudiger Klapdor Tomasz Kluz Bożena Konopka Susanne Krüger Kjær Jolanta Kupryjanczyk Diether Lambrechts Jenny Lester Jan Lubiński Douglas A Levine Lene Lundvall Valerie McGuire Iain A McNeish Usha Menon Francesmary Modugno Roberta B Ness Sandra Orsulic James Paul Celeste Leigh Pearce Tanja Pejovic Paul Pharoah Susan J Ramus Joseph Rothstein Mary Anne Rossing Matthias Rübner Joellen M Schildkraut Barbara Schmalfeldt Ira Schwaab Nadeem Siddiqui Weiva Sieh Piotr Sobiczewski Honglin Song Kathryn L Terry Els Van Nieuwenhuysen Adriaan Vanderstichele Ignace Vergote Christine S Walsh Penelope M Webb Nicolas Wentzensen Alice S Whittemore Anna H Wu Argyrios Ziogas Kunle Odunsi Jenny Chang-Claude Ellen L Goode Kirsten B Moysich

Cancer Epidemiol Biomarkers Prev 2017 03 27;26(3):420-424. Epub 2016 Sep 27.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EP
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-16-0631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500198PMC
March 2017

Sarcopenia in Advanced Serous Ovarian Cancer.

Int J Gynecol Cancer 2017 02;27(2):223-232

*Department of Gynecology and Obstetrics, Klinikum rechts der Isar, †Institute of Medical Statistics and Epidemiology, and ‡Department of Diagnostic and Interventional Radiology, Technische Universität München, Munich; and §Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000867DOI Listing
February 2017

Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48].

Thromb Res 2016 10 16;146:135. Epub 2016 Sep 16.

II. Medizinische Klinik und Poliklinik, Onkologisches Zentrum, Universitäres Cancer Center Hamburg (UCCH), Universitätsklinikum Eppendorf, Martinistr 52, D-20246 Hamburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2016.09.008DOI Listing
October 2016

Patterns of distant metastases in vulvar cancer.

Gynecol Oncol 2016 09 9;142(3):427-34. Epub 2016 Jul 9.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.07.009DOI Listing
September 2016

The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node.

Ann Surg Oncol 2016 08 8;23(8):2508-14. Epub 2016 Feb 8.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5114-6DOI Listing
August 2016

Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.

Thromb Res 2016 05 2;141:39-48. Epub 2016 Mar 2.

II. Medizinische Klinik und Poliklinik, Onkologisches Zentrum - Universitäres Cancer Center Hamburg (UCCH), Universitätsklinikum Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2016.03.002DOI Listing
May 2016

Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).

Gynecol Oncol 2016 Mar 28;140(3):450-6. Epub 2015 Dec 28.

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Gynäkologie und Geburtshilfe, Arnold-Heller-Str. 3, Haus 24, 24105 Kiel, Germany,. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.12.025DOI Listing
March 2016

The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study.

Int J Gynecol Cancer 2015 Sep;25(7):1248-52

*Department of Gynecology Charité, Campus Virchow Klinikum, Berlin, Germany; †Imperial College London, London, United Kingdom; ‡Gynäkologie & Gynäkologische Onkologie, Dr. Horst Schmidt Klinik, Wiesbaden; §Frauenklinik Universitätsklinikum Ulm, Ulm; ∥Coordinating Center for Clinical Trials, University Marburg, Marburg; ¶Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg; #Referenzzentrum für Gynäkopathologie, Institut für Pathologie, Mannheim; **Frauen- und Poliklinik, Klinikum der Technischen Universität, Muenchen; ††Frauenklinik Universitätsklinikum Tuebingen, Tuebingen; ‡‡Frauenheilkunde und Geburtshilfe, Klinikum der J.W. Goethe-Universität, Frankfurt; §§Klinik für Frauenheilkunde und Geburtshilfe der Universität Duisburg-Essen, Essen; ∥∥Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Technische Universität Dresden, Dresden; ¶¶Zentrum für Gynäkologische Onkologie, Kiel; ##Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; ***Universitätsklinik und Poliklinik für Gynäkologie, Universitätsklinikum, Halle; and †††Gynäkologie & Gynäkologische Onkologie, Kliniken Essen-Mitte, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000476DOI Listing
September 2015

Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.

Arch Gynecol Obstet 2015 Jul 26;292(1):231-4. Epub 2015 Apr 26.

Rotkreuzklinikum München, Frauenklinik, Taxisstraße 3, 80637, München, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-015-3697-yDOI Listing
July 2015

OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.

Oncol Lett 2015 Jan 24;9(1):418-424. Epub 2014 Oct 24.

Department of Obstetrics and Gynecology, Breast Center, Klinikum Grosshadern, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2014.2630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246645PMC
January 2015

Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.

Gynecol Oncol 2012 Dec 18;127(3):516-24. Epub 2012 Sep 18.

Department of Pathology, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.08.027DOI Listing
December 2012

Effect of platinum-containing chemotherapy on olfactory, gustatory, and hearing function in ovarian cancer patients.

Arch Gynecol Obstet 2012 Aug 6;286(2):473-80. Epub 2012 Apr 6.

Department of Otorhinolaryngology, Philipps University, Baldingerstrasse, 35033 Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-012-2307-5DOI Listing
August 2012

Ovarian cancer: diagnosis and treatment.

Dtsch Arztebl Int 2011 Sep 23;108(38):635-41. Epub 2011 Sep 23.

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe-Großhadern.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2011.0635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198226PMC
September 2011

Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients.

Virchows Arch 2010 Dec 19;457(6):705-13. Epub 2010 Oct 19.

Institut für Pathologie, Technische Universität München, Trogerstrasse 18, 81675, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-010-0986-5DOI Listing
December 2010

Gustatory and olfactory function in breast cancer patients.

Support Care Cancer 2010 Jun 3;18(6):707-13. Epub 2009 Jun 3.

Department of Otorhinolaryngology, Technical University, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-009-0672-9DOI Listing
June 2010

Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications.

Ann Surg 2009 Aug;250(2):288-92

Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e3181b0c7d8DOI Listing
August 2009

Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.

Acta Obstet Gynecol Scand 2009 ;88(4):440-8

Department of Medical Informatics, Biometry and Epidemiology, Munich Cancer Registry of the Munich Cancer Center, Ludwig-Maximilian-University, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1080/00016340902741208
Publisher Site
http://dx.doi.org/10.1080/00016340902741208DOI Listing
April 2009

Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer.

Hum Pathol 2007 Jun 30;38(6):926-34. Epub 2007 Mar 30.

Department of Pathology, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2006.12.008DOI Listing
June 2007

Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.

Clin Cancer Res 2007 Mar;13(6):1742-8

Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2482DOI Listing
March 2007

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.

Biol Chem 2006 Aug;387(8):1121-8

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
https://www.degruyter.com/view/j/bchm.2006.387.issue-8/bc.20
Publisher Site
http://dx.doi.org/10.1515/BC.2006.138DOI Listing
August 2006

Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.

Clin Cancer Res 2006 Mar;12(5):1487-93

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2106DOI Listing
March 2006

Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.

J Clin Oncol 2005 Oct 12;23(30):7445-53. Epub 2005 Sep 12.

University of Pittsburgh Medical Center, Division of Nuclear Medicine, 200 Lothrop St, Pittsburgh, PA, 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.06.965DOI Listing
October 2005

Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.

J Clin Oncol 2004 Feb;22(4):678-85

Department of Biochemistry and Molecular Biology, University of Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.05.144DOI Listing
February 2004

Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.

Cancer Res 2003 Jul;63(14):3958-65

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada.

View Article

Download full-text PDF

Source
July 2003

Human kallikrein 8, a novel biomarker for ovarian carcinoma.

Cancer Res 2003 Jun;63(11):2771-4

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada.

View Article

Download full-text PDF

Source
June 2003